Braidwell LP Guardant Health, Inc. Transaction History
Braidwell LP
- $1.63 Billion
- Q2 2025
A detailed history of Braidwell LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Braidwell LP holds 837,800 shares of GH stock, worth $46.2 Million. This represents 2.67% of its overall portfolio holdings.
Number of Shares
837,800
Previous 1,327,327
36.88%
Holding current value
$46.2 Million
Previous $56.5 Million
22.89%
% of portfolio
2.67%
Previous 3.47%
Shares
9 transactions
Others Institutions Holding GH
# of Institutions
415Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...